Aelian Biotechnology

Aelian Biotechnology Combines CRISPR Screening with Single-Cell Sequencing to Achieve Genetic Screening of Complex Phenotypes via Two Transformation Technologies. They utilize a CRISPR screening workflow to map the effects of thousands of genetic perturbations on the global transcriptome at single-cell resolution, effectively establishing a paradigm for the next generation of CRISPR screening. Aelian Biotechnology's approach has broad applications in identifying new drug targets or elucidating unknown mechanisms of drug action.